The Y-located proto-oncogene TSPY exacerbates and its X-homologue TSPX inhibits transactivation functions of androgen receptor and its constitutively active variants

Human Molecular Genetics

Volumn 26, Issue 5, 2017, Pages 901-912

  Li, Yunmin ^a,b   Zhang, Dong Ji ^a,b   Qiu, Yun ^c   Kido, Tatsuo ^a,b   Lau, Yun Fai Chris ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CHROMOSOME PROTEIN; ONCOPROTEIN; TESTIS SPECIFIC PROTEIN X ENCODED; TESTIS SPECIFIC PROTEIN Y ENCODED; TRANSCRIPTOME; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; NUCLEAR PROTEIN; SE20-4 PROTEIN, HUMAN; TSPY1 PROTEIN, HUMAN;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; COMPETITIVE INHIBITION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; LIGAND BINDING; LNCAP CELL LINE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTO ONCOGENE; RECEPTOR BINDING; TRANSACTIVATION; TRANSCRIPTOMICS; X CHROMOSOME; Y CHROMOSOME; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; GONADOBLASTOMA; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALE; PATHOLOGY; PROSTATE TUMOR; TESTIS; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GONADOBLASTOMA; HUMANS; MALE; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; PROTEIN DOMAINS; RECEPTORS, ANDROGEN; TESTIS; TRANSCRIPTIONAL ACTIVATION; TRANSCRIPTOME;

EID: 85019128007     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddx005     Document Type: Article

References (70)

1. Cunha, G.R., Ricke, W., Thomson, A., Marker, P.C., Risbridger, G., Hayward, S.W., Wang, Y.Z., Donjacour, A.A. and Kurita, T. (2004) Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J. Steroid Biochem. Mol. Biol., 92, 221-236.
2. Shen, M.M. and Abate-Shen, C. (2010) Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev., 24, 1967-2000.
3. Huang, C.K., Lee, S.O., Chang, E., Pang, H. and Chang, C. (2016) Androgen receptor (AR) in cardiovascular diseases. J. Endocrinol., 229, R1-R16.
4. Grgurevic, N. and Majdic, G. (2016) Sex differences in the brain-an interplay of sex steroid hormones and sex chromosomes. Clin. Sci. (Lond.), 130, 1481-1497.
5. Bayless, D.W. and Shah, N.M. (2016) Genetic dissection of neural circuits underlying sexually dimorphic social behaviours. Phil. Trans. R. Soc. London B Biol. Sci., 371, 20150109.
6. Lau, Y.F.C., Kido, T. and Li, Y. (2007) The TSPY Gene Family. In The Y Chromosome and Male Germ Cell Biology in Health and Diseases. Lau, Y.-F.C. and Chan, W.-Y. (eds.), World Scientific Publishers, pp. 73-90.
7. Skaletsky, H., Kuroda-Kawaguchi, T., Minx, P.J., Cordum, H.S., Hillier, L., Brown, L.G., Repping, S., Pyntikova, T., Ali, J., Bieri, T., et al. (2003) The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature, 423, 825-837.
8. Page, D.C. (1987) Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development, 101 Suppl, 151-155.
9. Honecker, F., Stoop, H., de Krijger, R.R., Chris Lau, Y.F., Bokemeyer, C. and Looijenga, L.H. (2004) Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J. Pathol., 203, 849-857.
10. Kido, T. and Lau, Y.F. (2005) A Cre gene directed by a human TSPY promoter is specific for germ cells and neurons. Genesis, 42, 263-275.
11. Lau, Y.F., Li, Y. and Kido, T. (2009) Gonadoblastoma locus and the TSPY gene on the human Y chromosome. Birth Defects Res. C. Embryo Today, 87, 114-122.
12. Li, Y., Tabatabai, Z.L., Lee, T.L., Hatakeyama, S., Ohyama, C., Chan, W.Y., Looijenga, L.H. and Lau, Y.F. (2007) The Yencoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors. Hum. Pathol., 38, 1470-1481.
13. Li, Y., Vilain, E., Conte, F., Rajpert-De Meyts, E. and Lau, Y.F. (2007) Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ. Urol. Oncol., 25, 141-146.
14. Kido, T., Hatakeyama, S., Ohyama, C. and Lau, Y.F. (2010) Expression of the Y-encoded TSPY is associated with progression of prostate cancer. Genes (Basel), 1, 283-293.
15. Kido, T., Lo, R.C., Li, Y., Lee, J., Tabatabai, Z.L., Ng, I.O. and Lau, Y.F. (2014) The potential contributions of a Y-located protooncogene and its X homologue in sexual dimorphisms in hepatocellular carcinoma. Hum. Pathol., 45, 1847-1858.
16. Oram, S.W., Liu, X.X., Lee, T.L., Chan, W.Y. and Lau, Y.F. (2006) TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer, 6, 154.
17. Li, Y. and Lau, Y.F. (2008) TSPY and its X-encoded homologue interact with cyclin B but exert contrasting functions on cyclin-dependent kinase 1 activities. Oncogene, 27, 6141-6150.
18. Kido, T., Schubert, S., Schmidtke, J. and Lau, Y.F. (2011) Expression of the human TSPY gene in the brains of transgenic mice suggests a potential role of this Y chromosome gene in neural functions. J. Genet. Genomics, 38, 181-192.
19. Kandalaft, L.E., Zudaire, E., Portal-Nunez, S., Cuttitta, F. and Jakowlew, S.B. (2008) Differentially expressed nucleolar transforming growth factor-beta1 target (DENTT) exhibits an inhibitory role on tumorigenesis. Carcinogenesis, 29, 1282-1289.
20. Kido, T., Ou, J.H. and Lau, Y.F. (2011) The X-linked tumor suppressor TSPX interacts and promotes degradation of the hepatitis B viral protein HBx via the proteasome pathway. PLoS One, 6, e22979.
21. Kido, T. and Lau, Y.F. (2008) The human Y-encoded testisspecific protein interacts functionally with eukaryotic translation elongation factor eEF1A, a putative oncoprotein. Int. J. Cancer, 123, 1573-1585.
22. Lau, Y.F., Lau, H.W. and Komuves, L.G. (2003) Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenet. Genome Res., 101, 250-260.
23. Muto, S., Senda, M., Akai, Y., Sato, L., Suzuki, T., Nagai, R., Senda, T. and Horikoshi, M. (2007) Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity. Proc. Natl. Acad. Sci. USA, 104, 4285-4290.
24. Wu, X., Wu, J., Huang, J., Powell, W.C., Zhang, J., Matusik, R.J., Sangiorgi, F.O., Maxson, R.E., Sucov, H.M. and Roy-Burman, P. (2001) Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech. Dev., 101, 61-69.
25. Guo, Z., Yang, X., Sun, F., Jiang, R., Linn, D.E., Chen, H., Chen, H., Kong, X., Melamed, J., Tepper, C.G., et al. (2009) A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth. Cancer Res., 69, 2305-2313.
26. Lu, J., Van der Steen, T. and Tindall, D.J. (2015) Are androgen receptor variants a substitute for the full-length receptor? Nat. Rev. Urol., 12, 137-144.
27. Antonarakis, E.S., Armstrong, A.J., Dehm, S.M. and Luo, J. (2016) Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting. Prostate Cancer Prostatic Dis., 19, 231-241.
28. Hockemeyer, D., Soldner, F., Cook, E.G., Gao, Q., Mitalipova, M. and Jaenisch, R. (2008) A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell, 3, 346-353.
29. Jin, C., Yang, L., Xie, M., Lin, C., Merkurjev, D., Yang, J.C., Tanasa, B., Oh, S., Zhang, J., Ohgi, K.A., et al. (2014) Chem-seq permits identification of genomic targets of drugs against androgen receptor regulation selected by functional phenotypic screens. Proc. Natl. Acad. Sci. USA, 111, 9235-9240.
30. Li, Y., Zheng, M. and Lau, Y.F. (2014) The sex-determining factors SRY and SOX9 regulate similar target genes and promote testis cord formation during testicular differentiation. Cell Rep., 8, 723-733.
31. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M. and Gingeras, T.R. (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics, 29, 15-21.
32. Liao, Y., Smyth, G.K. and Shi, W. (2014) featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics, 30, 923-930.
33. Love, M.I., Huber, W. and Anders, S. (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 550.
34. Bertrand, F.E., McCubrey, J.A., Angus, C.W., Nutter, J.M. and Sigounas, G. (2014) NOTCH and PTEN in prostate cancer. Adv. Biol. Regul., 56, 51-65.
35. Milella, M., Falcone, I., Conciatori, F., Cesta Incani, U., Del Curatolo, A., Inzerilli, N., Nuzzo, C.M., Vaccaro, V., Vari, S., Cognetti, F., et al. (2015) PTEN: multiple functions in human malignant tumors. Front. Oncol., 5, 24.
36. Packer, J.R. and Maitland, N.J. (2016) The molecular and cellular origin of human prostate cancer. Biochim. Biophys. Acta, 1863, 1238-1260.
37. Heidenreich, A., Bastian, P.J., Bellmunt, J., Bolla, M., Joniau, S., van der Kwast, T., Mason, M., Matveev, V., Wiegel, T., Zattoni, F., et al. (2014) EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur. Urol., 65, 124-137.
38. Watson, P.A., Arora, V.K. and Sawyers, C.L. (2015) Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat. Rev. Cancer, 15, 701-711.
39. Dehm, S.M. and Tindall, D.J. (2011) Alternatively spliced androgen receptor variants. Endocr. Relat. Cancer, 18, R183-R196.
40. Guo, Z. and Qiu, Y. (2011) A new trick of an old molecule: androgen receptor splice variants taking the stage?! Int. J. Biol. Sci., 7, 815-822.
41. Nakazawa, M., Antonarakis, E.S. and Luo, J. (2014) Androgen receptor splice variants in the era of enzalutamide and abiraterone. Horm. Cancer, 5, 265-273.
42. Antonarakis, E.S., Lu, C., Wang, H., Luber, B., Nakazawa, M., Roeser, J.C., Chen, Y., Mohammad, T.A., Chen, Y., Fedor, H.L., et al. (2014) AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N. Engl. J. Med., 371, 1028-1038.
43. Liu, L.L., Xie, N., Sun, S., Plymate, S., Mostaghel, E. and Dong, X. (2014) Mechanisms of the androgen receptor splicing in prostate cancer cells. Oncogene, 33, 3140-3150.
44. Lu, C. and Luo, J. (2013) Decoding the androgen receptor splice variants. Transl. Androl. Urol., 2, 178-186.
45. Sun, F., Chen, H.G., Li, W., Yang, X., Wang, X., Jiang, R., Guo, Z., Chen, H., Huang, J., Borowsky, A.D., et al. (2014) Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors. J. Biol. Chem., 289, 1529-1539.
46. Antonarakis, E.S. (2015) Predicting treatment response in castration-resistant prostate cancer: could androgen receptor variant-7 hold the key? Expert Rev. Anticancer Ther., 15, 143-145.
47. Sprenger, C., Uo, T. and Plymate, S. (2015) Androgen receptor splice variant V7 (AR-V7) in circulating tumor cells: coming of age of AR splice variants? Ann. Oncol., 26, 1805-1807.
48. Takeuchi, T., Okuno, Y., Hattori-Kato, M., Zaitsu, M. and Mikami, K. (2016) Detection of AR-V7 mRNA in whole blood may not predict the effectiveness of novel endocrine drugs for castration-resistant prostate cancer. Res. Rep. Urol., 8, 21-25.
49. Hu, D.G., Hickey, T.E., Irvine, C., Wijayakumara, D.D., Lu, L., Tilley, W.D., Selth, L.A. andMackenzie, P.I. (2014) Identification of androgen receptor splice variant transcripts in breast cancer cell lines and human tissues. Horm. Cancer, 5, 61-71.
50. Foley, C. and Mitsiades, N. (2016) Moving beyond the androgen receptor (AR): targeting AR-interacting proteins to treat prostate cancer. Horm. Cancer, 7, 84-103.
51. Culig, Z. (2016) Androgen receptor coactivators in regulation of growth and differentiation in prostate cancer. J. Cell. Physiol., 231, 270-274.
52. Epping, M.T., Lunardi, A., Nachmani, D., Castillo-Martin, M., Thin, T.H., Cordon-Cardo, C. and Pandolfi, P.P. (2015) TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFbeta signaling activation. Cell Death Differ., 22, 1353-1362.
53. Toh, B.H., Tu, Y., Cao, Z., Cooper, M.E. and Chai, Z. (2010) Role of cell division autoantigen 1 (CDA1) in cell proliferation and fibrosis. Genes (Basel), 1, 335-348.
54. McBeth, L., Grabnar, M., Selman, S. and Hinds, T.D. Jr. (2015) Involvement of the androgen and glucocorticoid receptors in bladder cancer. Int. J. Endorcinol., 2015, 384860.
55. Ma, W.L., Lai, H.C., Yeh, S., Cai, X. and Chang, C. (2014) Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocr. Relat. Cancer, 21, R165-R182.
56. Gudmundsson, J., Sulem, P., Rafnar, T., Bergthorsson, J.T., Manolescu, A., Gudbjartsson, D., Agnarsson, B.A., Sigurdsson, A., Benediktsdottir, K.R., Blondal, T., et al. (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat. Genet., 40, 281-283.
57. Sato, S., Maekawa, R., Yamagata, Y., Asada, H., Tamura, I., Lee, L., Okada, M., Tamura, H. and Sugino, N. (2014) Potential mechanisms of aberrant DNA hypomethylation on the x chromosome in uterine leiomyomas. J. Reprod. Dev., 60, 47-54.
58. Le Gallo, M., O'Hara, A.J., Rudd, M.L., Urick, M.E., Hansen, N.F., O'Neil, N.J., Price, J.C., Zhang, S., England, B.M., Godwin, A.K., et al. (2012) Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat. Genet., 44, 1310-1315.
59. Lai, M.C., Lombardo, M.V. and Baron-Cohen, S. (2014) Autism. Lancet, 383, 896-910.
60. Abel, K.M., Drake, R. and Goldstein, J.M. (2010) Sex differences in schizophrenia. Int. Rev. Psychiatry, 22, 417-428.
61. Li, Q., Chan, S.Y., Wong, K.K., Wei, R., Leung, Y.O., Ding, A.Y., Hui, T.C., Cheung, C., Chua, S.E., Sham, P.C., et al. (2016) Tspyl2 loss-of-function causes neurodevelopmental brain and behavior abnormalities in mice. Behav. Genet., 46, 529-537.
62. Moey, C., Hinze, S.J., Brueton, L., Morton, J., McMullan, D.J., Kamien, B., Barnett, C.P., Brunetti-Pierri, N., Nicholl, J., Gecz, J., et al. (2016) Xp11.2 microduplications including IQSEC2, TSPYL2 and KDM5C genes in patients with neurodevelopmental disorders. Eur. J. Hum. Genet., 24, 373-380.
63. Tsang, K.H., Lai, S.K., Li, Q., Yung, W.H., Liu, H., Mak, P.H., Ng, C.C., McAlonan, G., Chan, Y.S. and Chan, S.Y. (2014) The nucleosome assembly protein TSPYL2 regulates the expression of NMDA receptor subunits GluN2A and GluN2B. Sci. Rep., 4, 3654.
64. Vasli, N., Ahmed, I., Mittal, K., Ohadi, M., Mikhailov, A., Rafiq, M.A., Bhatti, A., Carter, M.T., Andrade, D.M., Ayub, M., et al. (2016) Identification of a homozygous missense mutation in LRP2 and a hemizygous missense mutation in TSPYL2 in a family with mild intellectual disability. Psychiatr. Genet., 26, 66-73.
65. Wang, G.S., Hong, C.J., Yen, T.Y., Huang, H.Y., Ou, Y., Huang, T.N., Jung, W.G., Kuo, T.Y., Sheng, M., Wang, T.F., et al. (2004) Transcriptional modification by a CASK-interacting nucleosome assembly protein. Neuron, 42, 113-128.
66. Chai, Z., Dai, A., Tu, Y., Li, J., Wu, T., Wang, Y., Hale, L.J., Koentgen, F., Thomas, M.C. and Cooper, M.E. (2013) Genetic deletion of cell division autoantigen 1 retards diabetesassociated renal injury. J. Am. Soc. Nephrol., 24, 1782-1792.
67. Wang, Y., Kasper, S., Yuan, J., Jin, R.J., Zhang, J., Ishii, K., Wills, M.L., Hayward, S.W. and Matusik, R.J. (2006) Androgen-dependent prostate epithelial cell selection by targeting ARR(2)PBneo to the LPB-Tag model of prostate cancer. Lab. Invest., 86, 1074-1088.
68. Oh, H.J., Li, Y. and Lau, Y.F. (2005) Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. Biol. Reprod., 72, 407-415.
69. Dong, X., Sweet, J., Challis, J.R., Brown, T. and Lye, S.J. (2007) Transcriptional activity of androgen receptor is modulated by two RNA splicing factors, PSF and p54nrb. Mol. Cell. Biol., 27, 4863-4875.
70. Giardine, B., Riemer, C., Hardison, R.C., Burhans, R., Elnitski, L., Shah, P., Zhang, Y., Blankenberg, D., Albert, I., Taylor, J., et al. (2005) Galaxy: a platform for interactive large-scale genome analysis. Genome Res., 15, 1451-1455.